3rd Quarter - Amendment
BGR GOVERNMENT AFFAIRS for AMARIN PHARM INC.
Client
Income
$80,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (No Activity) | Oct 21, 2019 | — | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 22, 2019 | $80,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide guidance and strategic counsel with regard to regulations and legislation that could impact the pharmaceutical industry generally, and Amarin specifically
Foreign entity interest: Amarin Corporation plc 100%
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT ALAN DEL MONTE | see prior filing |
| MATT HOFFMANN | see prior filing |
| REMY LEIGH BRIM MASON | see prior filing |
| JOHN STONE | See prior filing |
| ROBB WALTON | see prior filing |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.